Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Especificaciones del compuesto Synthetic Pentadecapeptide Laboratory Research Use Only Detalles del producto Tamaos: 5mg, 10mg Compuesto: BPC-157 Secuencia: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val CAS: 137525-51-0 Molecular Weight: 1419.53 Da Forma: Polvo liofilizado Documentation: Batch-specific analytical records where available Pruebas: View COA documentation Pruebas: Ver COA (Verificado por Janoshik) BPC-157 documentation path This page is built as a documentation-first reference page for researchers comparing compound identity, vial size, analytical records, and literature context
Many people use BPC-157 for sleep because it reduces pain and improves rest
Always reconstitute using sterile laboratory-grade solvents and handle with aseptic technique to prevent contamination
When to Be Concerned: Abnormal or Severe Reactions While most site reactions are benign, certain signs indicate a need for intervention : Warning Signs: Spreading redness or a halo that increases in size Severe pain that intensifies rather than resolves Hard, painful lump that doesnt go away after several days Pus , drainage, or signs of infection Blistering or skin breakdown Fever , chills, or flu-like symptoms Allergic reaction systemic itching, rash, or anaphylaxis (very rare) If you experience any of the above, stop using the peptide and contact your provider immediately
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Funding This research was funded by National Natural Science Foundation of China (grants No
US$ 29.20
US$ 25.18
US$ 28.54
